• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Risk Mitigation Strategies to Address Potential Procoagulant Activity in Immune Globulin Products Presentations

Persons with disabilities having problems accessing the PDF files on this page may call 301-796-0720 for assistance.